Invesco
RXST icon

Invesco’s RxSight RXST Stock Holding History

Invesco’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326K Buy
52,904
+32,790
+163% +$272K ﹤0.01% 3308
2025
Q4 		$210K Buy
20,114
+1,249
+7% +$12.5K ﹤0.01% 3508
2025
Q3 		$170K Sell
18,865
-1,218
-6% -$10.7K ﹤0.01% 3596
2025
Q2 		$261K Buy
20,083
+80
+0.4% +$1.2K ﹤0.01% 3422
2025
Q1 		$505K Sell
20,003
-371,160
-95% -$11M ﹤0.01% 3146
2024
Q4 		$13.4M Sell
391,163
-596,434
-60% -$26.9M ﹤0.01% 1677
2024
Q3 		$48.8M Sell
987,597
-66,586
-6% -$3.41M 0.01% 1043
2024
Q2 		$63.4M Buy
1,054,183
+285,228
+37% +$16.3M 0.01% 918
2024
Q1 		$39.7M Buy
768,955
+525,138
+215% +$25.8M 0.01% 1140
2023
Q4 		$9.83M Buy
243,817
+115,466
+90% +$3.39M ﹤0.01% 1828
2023
Q3 		$3.58M Sell
128,351
-40,372
-24% -$1.2M ﹤0.01% 2376
2023
Q2 		$4.86M Buy
168,723
+35,824
+27% +$797K ﹤0.01% 2259
2023
Q1 		$2.22M Buy
+132,899
New +$1.88M ﹤0.01% 2591

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Invesco's RXST Position: Q1 2026 in Review

Invesco increased its RxSight (RXST) stake by 163% in Q1 2026, buying an estimated $272K and bringing the position to 52,904 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3308.

Invesco first reported a position in RXST in Q1 2023 and has held it in 13 quarters since. The position peaked at $63.4M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Invesco held 52,904 shares of RxSight worth $326K as of Q1 2026.
  • Invesco bought 32,790 RxSight shares in Q1 2026, an estimated $272K.
  • RxSight made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3308 holding.
  • Invesco first reported a position in RxSight in Q1 2023 and has held it in 13 quarters since.
  • Invesco's RxSight position peaked at $63.4M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.